疾病诊断相关分组支付背景下关于儿科中医非药物疗法的思考

吴蕙宏; 张红晓; 刘子旺; 朱晓杰; 陈梓昕

doi:10.19546/j.issn.1674-3830.2025.5.008

中国医疗保险 ›› 2025, Vol. 0 ›› Issue (5) : 59-63. DOI: 10.19546/j.issn.1674-3830.2025.5.008

专题分析

疾病诊断相关分组支付背景下关于儿科中医非药物疗法的思考

吴蕙宏¹, 张红晓², 刘子旺¹, 朱晓杰¹, 陈梓昕¹

作者信息 +

Reflections on Traditional Chinese Medicine Non-Drug Therapies in Pediatrics Under the DRG Payment System

Author information +

文章历史 +

摘要

中医非药物疗法在儿科临床实践中有着不可替代的关键价值,然而由于其自身特点,中医非药物疗法融入DRG支付体系面临诸多现实困境。本文建议明确儿科中医优势病种,构建儿科中医分组编码,调整儿科中医非药物疗法支付标准,打造儿科中医日间病房,以期更好地推动儿科中医非药物疗法的发展,使其在儿科医疗服务中发挥更大的作用。

Abstract

Traditional Chinese medicine (TCM) non-drug therapies have an irreplaceable value in pediatric clinical practice. However, due to their own characteristics, the integration of TCM non-drug therapies into the DRG payment system faces many practical difficulties. The paper proposes to clarify the pediatric dominant diseases of TCM, construct a unique grouping code for pediatric TCM, adjust the payment standard for TCM non-drug therapies in pediatrics, and create a pediatric TCM ambulatory ward, so as to better promote the development of TCM pediatric non-drug therapies and enable them to play more important role in pediatric medical services.

导出引用

吴蕙宏, 张红晓, 刘子旺, 朱晓杰, 陈梓昕. 疾病诊断相关分组支付背景下关于儿科中医非药物疗法的思考[J]. 中国医疗保险. 2025, 0(5): 59-63 https://doi.org/10.19546/j.issn.1674-3830.2025.5.008

Reflections on Traditional Chinese Medicine Non-Drug Therapies in Pediatrics Under the DRG Payment System[J]. China Health Insurance. 2025, 0(5): 59-63 https://doi.org/10.19546/j.issn.1674-3830.2025.5.008

中图分类号： F840.684 C913.7

参考文献

[1] BLANPIED P R, GROSS A R, ELLIOTT J M, et al.Neck pain: revision 2017[J].Journal of orthopaedic & sports physical therapy, 2017, 47(7):A1-A83.
[2] 陶丽丽,马晓昌.从高血压指南看中医“治未病”非药物疗法的重要性[J].中华中医药杂志,2018,33(11):4859-4862.
[3] 刘斌.浅谈芒针疗法的特点[J].河南中医,2000(06):56.
[4] 王少君,廖藏宜,徐梦秋,等.浙江:DRG支付体系下的中医倾斜机制[J].中国卫生,2022(12):90-91.
[5] 石连忠,梅彦,余震,等.杭州市DRG中医支付政策的实践探索[J].卫生经济研究,2021,38(12):16-19.
[6] 马艳,范珊红,高丽,等.护理服务价格体系现状分析与对策[J].护理研究,2016,30(31):3932-3934.
[7] 韩琳,畅雪,马玉霞,等.基于RBRVS和TDABC法的胆囊结石单病种护理的成本核算[J].重庆医学,2021,50(13):2323-2327.
[8] 马欣彤,邓婕,宋喜国,等.儿科DRG病种组成本比价关系研究[J].中国卫生经济,2022,41(08):40-42.
[9] 高阳,祖亮华,刘冉,等.中医纳入疾病诊断相关分组的思考[J].卫生经济研究,2023,40(11):5-8.
[10] 刘同心,张加奇,周良荣.基于价值医疗理论的中医医疗服务定价现状与思考[J].卫生经济研究,2022,39(08):68-72.
[11] 彭美华,朱旭林,肖蕾,等.DRG支付背景下中医药传承创新发展的困境与对策研究——基于骨伤科病例分析[J].中医药管理杂志,2022,30(13):3-6.
[12] 李希,邓世虎,彭美华,等.中医优势病种DRG付费:政策、难点及对策[J].卫生经济研究, 2025,42(01):39-42+47.
[13] 廖藏宜,秦纪华,蓝志成.中医优势病种按疗效价值付费的柳州经验[J].卫生经济研究, 2023,40(06):61-63+67.
[14] 殷人易,彭朗,张瑶,等.武汉市某三甲医院针灸科DRG入组情况分析及探讨[J].医学与社会, 2020,33(03):80-82+87.
[15] 周莹,刘敏,刘秀娟,等.中医日间病房病种纳入中医DRG分组研究[J].中国医疗保险,2025(01):22-27.